IFP Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2
| Closed | -$25 | – | 5068 |
|
|
2025
Q1 | $25 | Hold |
2
| – | – | ﹤0.01% | 4141 |
|
|
2024
Q4 | $25 | Buy |
+2
| New | +$23 | ﹤0.01% | 4422 |
|
|
2023
Q1 | – | Sell |
-75
| Closed | -$2K | – | 4519 |
|
|
2022
Q4 | $2K | Sell |
75
-1
| -1% | -$15 | ﹤0.01% | 4247 |
|
|
2022
Q3 | $2K | Hold |
76
| – | – | ﹤0.01% | 4437 |
|
|
2022
Q2 | $2K | Hold |
76
| – | – | ﹤0.01% | 4222 |
|
|
2022
Q1 | $2K | Buy |
+76
| New | +$1.55K | ﹤0.01% | 4220 |
|
|
2019
Q1 | $17K | Buy |
4,000
+3,100
| +344% | +$12.6K | ﹤0.01% | 1416 |
|
|
2018
Q4 | $4K | Hold |
900
| – | – | ﹤0.01% | 2971 |
|
|
2018
Q3 | $6K | Sell |
900
-2,143
| -70% | -$12.7K | ﹤0.01% | 3154 |
|
|
2018
Q2 | $12K | Hold |
3,043
| – | – | ﹤0.01% | 2800 |
|
|
2018
Q1 | $12K | Hold |
3,043
| – | – | ﹤0.01% | 2695 |
|
|
2017
Q4 | $12K | Sell |
3,043
-531
| -15% | -$2.27K | ﹤0.01% | 2732 |
|
|
2017
Q3 | $11K | Buy |
3,574
+3
| +0.1% | +$11 | ﹤0.01% | 2978 |
|
|
2017
Q2 | $15K | Hold |
3,571
| – | – | ﹤0.01% | 2769 |
|
|
2017
Q1 | $16K | Buy |
3,571
+2,142
| +150% | +$7.18K | ﹤0.01% | 2657 |
|
|
2016
Q4 | $3K | Sell |
1,429
-285
| -17% | -$666 | ﹤0.01% | 3555 |
|
|
2016
Q3 | $5K | Hold |
1,714
| – | – | ﹤0.01% | 3265 |
|
|
2016
Q2 | $4K | Buy |
1,714
+1,143
| +200% | +$3.19K | ﹤0.01% | 3275 |
|
|
2016
Q1 | $17K | Sell |
571
-1,143
| -67% | -$6.12K | ﹤0.01% | 1416 |
|
|
2015
Q4 | $14K | Buy |
+1,714
| New | +$13.8K | ﹤0.01% | 2403 |
|
IFP Advisors's CDMO Position: Q2 2025 in Review
IFP Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2025, closing a stake of 2 shares — an estimated $25 sold.
IFP Advisors first reported a position in CDMO in Q4 2015 and held it in 20 quarters. The position peaked at $17K in Q1 2019. 0 funds tracked by Wall St. Rank hold CDMO as of Q2 2025.
- IFP Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
- IFP Advisors sold 2 Avid Bioservices, Inc. Common Stock shares in Q2 2025, an estimated $25.
- IFP Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2015 and held it in 20 quarters.
- IFP Advisors's Avid Bioservices, Inc. Common Stock position peaked at $17K in Q1 2019.
- 0 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2025.
Based on IFP Advisors's 13F filing for Q2 2025, filed 24 Jul 2025.